Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
|Pia Marions||56||2013||Independent Director|
|Lars Holmqvist||60||2018||Independent Director|
|Barbro Friden||63||2010||Independent Director|
|Mark Larman||45||2017||Chief Scientific Officer|
|Maria Forss||47||2019||Vice President Consumables|
|Claus Bisgaard||42||-||Vice President Technology|
|Rickard Ericsson||48||2017||Chief Sales & Marketing Officer|
|Mikael Engblom||42||2017||Chief Financial Officer|
|Fredrik Mattsson||47||2018||Senior Vice President New Business & Strategic Development|
|Jon Sigurdsson||63||2019||Chairman of the Board|
|Thomas Axelsson||60||2017||Chief Executive Officer|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.